Trials / Terminated
TerminatedNCT02978378
Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The investigators objective is to assess the utility of renal biomarkers in predicting renal recovery following institution of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). Tissue biomarkers of renal injury may provide a real-time indication of renal function and the likelihood of renal recovery in patients having cardiogenic shock and requiring VA-ECMO. In these patients, traditional markers of kidney function (urine output and serum Creatinine level) do not accurately represent renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biomarker levels | The level of the biomarker hyaluronic acid will be measured |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2018-03-23
- Completion
- 2018-03-23
- First posted
- 2016-11-30
- Last updated
- 2024-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02978378. Inclusion in this directory is not an endorsement.